VanEck Pharmaceutical ETF Rating $112.18 +2.95 (+2.70%) As of 01:07 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.59Holdings in PPH have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 22 companies (88.1% of the portfolio).PPH Aggregate Price Target$111.81-0.33% DownsideHigh Prediction$111.81Average Prediction$111.81Low Prediction$111.81Holdings in PPH have an aggregate price target of $111.81 and a range of $111.81 to $111.81 covering 22 companies (88.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings20.95%LLYEli Lilly and Company$1,210.51+3.8%Moderate Buy$1,313.43 8.5%294.7386 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision13.17%MRKMerck & Co., Inc.$147.35+3.8%Moderate Buy$151.92 3.1%274.5203 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision5.61%NVONovo Nordisk A/S$38.15+0.2%Hold$59.44 55.8%264.0674 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision5.04%PFEPfizer$29.30+3.3%Hold$28.72 -2.0%212.9106 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision4.73%MCKMcKesson$971.16+1.0%Moderate Buy$983.29 1.2%194.5084 of 5 stars4.71%BMYBristol Myers Squibb$58.62+3.4%Hold$64.88 10.7%304.6689 of 5 starsTrending NewsAnalyst Forecast4.48%CORCencora$333.54+1.0%Moderate Buy$365.69 9.6%184.696 of 5 starsAnalyst Forecast4.39%GSKGSK$47.84+3.4%Hold$55.33 15.7%193.7738 of 5 starsTrending NewsDividend Cut3.74%ABBVAbbVie$284.30+3.6%Moderate Buy$277.18 -2.5%304.0001 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.68%HLNHaleon$9.66+2.3%Moderate Buy92.9252 of 5 stars3.36%JNJJohnson & Johnson$252.62+1.6%Moderate Buy$273.61 8.3%254.4879 of 5 starsTrending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.25%SNYSanofi$39.87+1.9%Hold$49.50 24.2%214.3506 of 5 stars2.73%TAKTakeda Pharmaceutical$18.96+2.3%Moderate Buy42.0266 of 5 stars2.55%ZTSZoetis$75.64+1.8%Hold$101.08 33.6%194.529 of 5 starsDividend Announcement1.50%VTRSViatris$17.79+3.1%Moderate Buy$20.50 15.3%93.1233 of 5 stars1.33%JAZZJazz Pharmaceuticals$213.33+1.4%Buy$291.25 36.5%204.2237 of 5 stars0.81%CORTCorcept Therapeutics$120.01+1.9%Moderate Buy$138.17 15.1%83.8959 of 5 stars0.70%AXSMAxsome Therapeutics$162.31+3.8%Moderate Buy$275.74 69.9%213.1536 of 5 starsAnalyst Forecast0.51%ELANElanco Animal Health$22.57+0.7%Moderate Buy$29.70 31.6%123.8091 of 5 stars0.46%DFTXDefinium Therapeutics$34.47+0.3%Moderate Buy$66.00 91.5%213.3099 of 5 stars0.29%OGNOrganon & Co.$13.770.0%Reduce$11.40 -17.2%71.3636 of 5 starsNews Coverage0.10%PRGOPerrigo$15.89+3.4%Hold$19.33 21.7%63.3889 of 5 starsNews Coverage This page (NASDAQ:PPH) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
